title: Inhibitor of differentiation 4 (ID4): From development to cancer.
abstract: Highly conserved Inhibitors of DNA-Binding (ID1-ID4) genes encode multi-functional proteins whose transcriptional activity is based on dominant negative inhibition of basic helix-loop-helix (bHLH) transcription factors. Initial animal models indicated a degree of compensatory overlap between ID genes such that deletion of multiple ID genes was required to generate easily recognizable phenotypes. More recently, new model systems have revealed alterations in mice harboring deletions in single ID genes suggesting complex gene and tissue specific functions for members of the ID gene family. Because ID genes are highly expressed during development and their function is associated with a primitive, proliferative cellular phenotype there has been significant interest in understanding their potential roles in neoplasia. Indeed, numerous studies indicate an oncogenic function for ID1, ID2 and ID3. In contrast, the inhibitor of differentiation 4 (ID4) presents a paradigm shift in context of well-established role of ID1, ID2 and ID3 in development and cancer. Apart from some degree of functional redundancy such as HLH dependent interactions with bHLH protein E2A, many of the functions of ID4 are distinct from ID1, ID2 and ID3: ID4 proteins a) regulate distinct developmental processes and tissue expression in the adult, b) promote stem cell survival, differentiation and/or timing of differentiation, c) epigenetic inactivation/loss of expression in several advanced stage cancers and d) increased expression in some cancers such as those arising in the breast and ovary. Thus, in spite of sharing the conserved HLH domain, ID4 defies the established model of ID protein function and expression. The underlying molecular mechanism responsible for the unique role of ID4 as compared to other ID proteins still remains largely un-explored. This review will focus on the current understanding of ID4 in context of development and cancer.
authors.affiliation: Department of Biological Sciences, Center for Cancer Research and Therapeutics Development, Clark Atlanta University, Atlanta, GA 30314, USA.
authors.forename: Divya
authors.initials: D
authors.lastname: Patel
authors.affiliation: Department of Biological Sciences, Center for Cancer Research and Therapeutics Development, Clark Atlanta University, Atlanta, GA 30314, USA.
authors.forename: Derrick J
authors.initials: DJ
authors.lastname: Morton
authors.affiliation: Department of Experimental Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Jason
authors.initials: J
authors.lastname: Carey
authors.affiliation: Norris Cotton Cancer Center and Geisel Medical School at Dartmouth, Lebanon, NH, USA.
authors.forename: Mathew C
authors.initials: MC
authors.lastname: Havrda
authors.affiliation: Department of Biological Sciences, Center for Cancer Research and Therapeutics Development, Clark Atlanta University, Atlanta, GA 30314, USA. Electronic address: jchaudhary@cau.edu.
authors.forename: Jaideep
authors.initials: J
authors.lastname: Chaudhary
mesh_terms: D000328:Adult; D000595:Amino Acid Sequence; D000818:Animals; D002454:Cell Differentiation; D048788:Growth and Development / Q000235:genetics*; D006801:Humans; D051796:Inhibitor of Differentiation Proteins / Q000737:chemistry / Q000145:classification / Q000502:physiology*; D051379:Mice; D018345:Mice, Knockout; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology; D010802:Phylogeny; D017385:Sequence Homology
chemical_list: C490128:ID4 protein, human; D051796:Inhibitor of Differentiation Proteins
keywords: Cancer; Development; Differentiation; Epigenetics; ID4; bHLH